The 2015 Grover Conference

2015年格罗弗会议

基本信息

  • 批准号:
    8984749
  • 负责人:
  • 金额:
    $ 0.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-08-01 至 2016-04-29
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The 2015 Grover Conference, `The Pulmonary Circulation and RV in the `-omics' era: new insights into pathogenesis', will focus upon the molecular mechanisms of pulmonary vascular disease and right ventricular dysfunction. This is the 17th biannual conference of developmental and cellular biologists, geneticists, physiologists, biochemists, and translational researchers with a primary interest in the pulmonary circulation and right ventricular response to stress; it is unique for its intimate forum which brings together scientists and physician-scientists of all stages of scientific interest and career progression. Th platform sessions will highlight various types of `-omics' technologies and the recent discoveries of relevance to pulmonary vascular disease. Each session will be chaired by an expert in the field and will have invited speakers as well as platform speakers chosen from the pool of submitted abstracts. Among session highlights will be a focus on the use of systems biology approaches to integrate data across multiple platforms to advance the scientific discoveries. There has been a conscious effort to attract established investigators from related disciplines who can complement the expertise of the current pool of investigators focused on the pulmonary vasculature, as well as an effort to include the RV. Discussion facilitated by a discussion leader will be an important component of all sessions. Outstanding junior investigators will be awarded travel grants and will be given the opportunity to present their research in platform and poster formats. The poster sessions will be organized thematically and will be designed to relate to the topics presented in the platform sessions that day. All conference participants dine and socialize together in an informal setting which is conducive to discussion and collaboration. Every effort will be made to include women and underrepresented minorities among the presenters. The Conference goals is to provide a forum for to discuss the molecular and cellular basis of lung disease, to present cutting edge research, to integrate concepts and to identify creative and innovative research directions. 1
 描述(由适用提供):2015年Grover会议,“`` - 组学时''时代的肺循环和RV:对发病机理的新见解,将集中在肺血管疾病和右心室功能障碍的分子机制上。这是第17届发育和细胞生物学家,遗传学家,生理学家,生物化学家和转化研究人员的第17届双年展会议,对肺循环和对压力的右心室反应具有主要兴趣;它的独立论坛是独一无二的 科学兴趣和职业发展的各个阶段的科学家和身体科学家。该平台会议将重点介绍各种类型的“ - 组”技术以及与肺血管疾病相关的最新发现。每个会议将由该领域的专家主持,并将邀请演讲者以及从提交摘要库中选出的平台演讲者。会议亮点将重点放在使用系统生物学方法的使用,以跨多个平台进行集成数据以提高科学发现。已经有意识地努力吸引来自相关学科的既定调查员,他们可以补充目前专注于肺部脉管系统的研究人员的专业知识,并努力包括RV。讨论负责人准备的讨论将是所有会议的重要组成部分。杰出的初级调查人员将获得旅行补助金,并将有机会以平台和海报格式介绍他们的研究。海报会议将以主题组织组织,并将设计为与当天平台会议中介绍的主题有关。所有会议参与者在非正式的环境中用餐并共同进行讨论和协作。将竭尽全力将妇女和代表性不足的少数群体包括在演讲者中。会议目标是为讨论肺部疾病的分子和细胞基础的论坛提供一个论坛,以提出尖端研究,整合概念并确定创造性和创新的研究指示。 1

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eric Douglas Austin其他文献

Eric Douglas Austin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eric Douglas Austin', 18)}}的其他基金

Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals
肺动脉高压和遗传易感人群的风险和恢复能力
  • 批准号:
    10573886
  • 财政年份:
    2022
  • 资助金额:
    $ 0.8万
  • 项目类别:
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals
肺动脉高压和遗传易感人群的风险和恢复能力
  • 批准号:
    10705768
  • 财政年份:
    2022
  • 资助金额:
    $ 0.8万
  • 项目类别:
Variations in estrogen exposures may modify pulmonary arterial hypertension
雌激素暴露的变化可能会改变肺动脉高压
  • 批准号:
    8669054
  • 财政年份:
    2010
  • 资助金额:
    $ 0.8万
  • 项目类别:
Variations in estrogen exposures may modify pulmonary arterial hypertension
雌激素暴露的变化可能会改变肺动脉高压
  • 批准号:
    8117707
  • 财政年份:
    2010
  • 资助金额:
    $ 0.8万
  • 项目类别:
Variations in estrogen exposures may modify pulmonary arterial hypertension
雌激素暴露的变化可能会改变肺动脉高压
  • 批准号:
    7989599
  • 财政年份:
    2010
  • 资助金额:
    $ 0.8万
  • 项目类别:
Variations in estrogen exposures may modify pulmonary arterial hypertension
雌激素暴露的变化可能会改变肺动脉高压
  • 批准号:
    8477240
  • 财政年份:
    2010
  • 资助金额:
    $ 0.8万
  • 项目类别:
Variations in estrogen exposures may modify pulmonary arterial hypertension
雌激素暴露的变化可能会改变肺动脉高压
  • 批准号:
    8269668
  • 财政年份:
    2010
  • 资助金额:
    $ 0.8万
  • 项目类别:

相似海外基金

Novel application of pharmaceutical AMD3100 to reduce risk in opioid use disorder: investigations of a causal relationship between CXCR4 expression and addiction vulnerability
药物 AMD3100 降低阿片类药物使用障碍风险的新应用:CXCR4 表达与成瘾脆弱性之间因果关系的研究
  • 批准号:
    10678062
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
Mentoring Emerging Researchers at CHLA (MERCH-LA)
指导 CHLA (MERCH-LA) 的新兴研究人员
  • 批准号:
    10797938
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
Sleep-Wake Cycles of Individuals with Inflammatory Bowel Disease
炎症性肠病患者的睡眠-觉醒周期
  • 批准号:
    10604701
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
Novel Combinations of Natural Product Compounds for Treatment of Alzheimer Disease and Related Dementias
用于治疗阿尔茨海默病和相关痴呆症的天然产物化合物的新组合
  • 批准号:
    10603708
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
A Potent D-peptide Inhibitor of TNFα for Treatment of Rheumatoid Arthritis
一种有效的 TNFα D 肽抑制剂,用于治疗类风湿性关节炎
  • 批准号:
    10822182
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了